tyrosine has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bramanti, P; Cuzzocrea, S; Di Paola, R; Galuppo, M; Mazzon, E; Paterniti, I | 1 |
| Georgieff, MK; Goertz, R; Mammel, MC; Premer, DM; Schwarzenberg, SJ | 1 |
2 other study(ies) available for tyrosine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan | 2010 |
Muscle proteolysis and weight loss in a neonatal rat model of sepsis syndrome.
Topics: Animals; Animals, Newborn; Anorexia; Diarrhea; Injections, Intraperitoneal; Lipopolysaccharides; Models, Animal; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle Proteins; Nitrogen; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha; Tyrosine; Weight Loss | 2002 |